RNS Number : 9575F
NetScientific PLC
26 February 2015
 



NetScientific plc

("NetScientific" or the "Group")

 

Appointment to the Board

 

NetScientific appoints Jonathan Paisner as Non-Executive Director

 

26 February 2015: NetScientific (AIM: NSCI), the biomedical and healthcare technology group is pleased to announce that Jonathan Paisner will join the Board with immediate effect as a non-executive director.

 

Jonathan is the founder of LMN Capital Limited, a corporate finance advisor which helps management teams access capital from a wide range of investors.  He is also a consultant lawyer at law firm Mathias Gentle Page Hassan and has acted as a consultant to NetScientific. Previously, he was on the board of boutique investment bank Shore Capital. He is being appointed by the Azima Family Trusts pursuant to their rights under NetScientific's Articles of Association to nominate a director.

 

Commenting on the appointment, Sir Richard Sykes, Executive Chairman of NetScientific, said, "Jonathan's appointment will further strengthen the Board and the Company's position in 2015.  His expertise and experience, particularly in accessing capital and structuring deals, will be valuable in advancing the Group's strategy in 2015 and beyond."

 

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies. Jonathan Paisner, aged 45 years, has been a director of the following companies during the five years preceding the date of this announcement:

 

 Current directorships

Past Directorships

LMN Capital Limited

Shore Capital Group plc (now Shore Capital Group Ltd)

LMN Capital Partners Limited

Puma Hotels plc

Beautyv Limited

Chic Lifestyle Limited

The Fabedit Limited

Chic Retreats Limited

British Friends of Hebrew University of  Jerusalem

Ourpinboard Limited

Crowdsyndicator Limited

 

-Ends-

Notes to Editors

 

About NetScientific

 

NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.NetScientific.net 

 

Contact Details

 

Liberum (NOMAD and Broker)

Chris Bowman / Christopher Britton

Tel: +44 (0) 20 3100 2000

Instinctif Partners

Melanie Toyne-Sewell / Tim Watson

Tel: +44 (0) 20 7457 2020 Email: netscientific@instinctif.com 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFIIFSIRFIE